Nature

Print ISSN
0028-0836
Electronic ISSN
1476-4687
Impact factor
36.104
Publisher
nature
URL
http://www.nature.com/nature/
Usage rank
5
Article count
103083
Free count
6953
Free percentage
0.0674505
PDFs via platforms
Nature, Gale, Ovid from 2002, CSA, and Proquest

  1. The antibody aducanumab reduces A? plaques in Alzheimer's disease.

    Nature 537(7618):50 (2016) PMID 27582220

    Alzheimer's disease (AD) is characterized by deposition of amyloid-_ (A_) plaques and neurofibrillary tangles in the brain, accompanied by synaptic dysfunction and neurodegeneration. Antibody-based immunotherapy against A_ to trigger its clearance or mitigate its neurotoxicity has so far been uns...